KCT0001737
Completed
未知
A 12 week, randomized, double-blind and placebo-controlled clinical trial to assess the efficacy and safety of soy isoflavone in postmenopausal women
Dr.Chung's Food0 sites96 target enrollmentTBD
ConditionsDiseases of The genitoruinary system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of The genitoruinary system
- Sponsor
- Dr.Chung's Food
- Enrollment
- 96
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?last spontaneous menstrual bleeding\>12 month ago, aged 45\-60 years
- •?hot flushes continued for at least three month
- •?Kupperman index ranged 20 to 40
- •?Serum follicle\-stimulating hormone (FSH) levels \>\= 40 IU /ml.
- •?BMI ranging between 19\.0 to 30 kg/m2
- •?Written informed consent
Exclusion Criteria
- •? women who have hysterectomy or chemotherapy
- •? women who have abnormal finding such as endometrial proliferation, endometrial cancer and uterine cervical cancer related condition
- •? women who have breast cancer related condition
- •? women who received hormone replacement therapy or selective estrogen receptor modulators (SERMS) within five years of enrollment
- •? women who vaginal bleeding, unknown cause within six month of enrollment
- •? Women who have heart, kidney and thyroid disease
- •? Women who have depression and schizophrenia
- •? women who received hormone replacement therapy or selective estrogen receptor modulators (SERMS) within three month of enrollment
- •? Patient with systolic blood pressure \=170 mmHg and diastolic pressure \=100 mmHg, or hypertensive person who take diuretics (170/100 mmHg, at the screening)
- •? who had uncontrolled bood glucose (IFG 180 mg/dl mmHg, at the screening)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A 12 weeks, randomized, double-blinded, placebo-controlled study of KBH-HM01 to evaluate efficacy and safety on immune functioKCT0005707KolmarBNH100
Recruiting
Not Applicable
A human trial of Gastrodia elata Blume and Glycyrrhiza uralensis Fischer extracts mixture on improvement of Cognitive(memory) FunctioKCT0007338Wonkwang University, Gwangju Medical Center100
Completed
Not Applicable
A 12 weeks, randomized, double-blind, placebo-controlled human trial of unripe Bokbunja Extract on decrease of body fatEndocrine, nutritional and metabolic diseasesKCT0006298Wonkwang University. Iksan Korean Medicine Hospital140
Completed
Not Applicable
A human trial to evaluate the efficacy and safety of Gastrodia elata Blume extract on improvement of Cognitive FunctioKCT0006605Wonkwang University. Iksan Korean Medicine Hospital100
Completed
Not Applicable
A human trial to evaluate the efficacy and safety of Angelica gigas N. extract powder(Nutragen) on joint healthKCT0004587Wonkwang University Oriental Medical Hospital, Jeonju80